Research summary, original research, 2017

Pushing the limits: establishing an ultra-low framerate and antiscatter grid-less radiation protocol for left atrial ablations

Attanasio P, Schreiber T, Pieske B, Blaschke F, Boldt LH, Haverkamp W, et al.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017

Read the original paper

In plain language

In 150 left atrial ablations at one centre, halving the frame rate and removing the antiscatter grid cut patient dose area product by 64% without longer procedures. Staff dose was not measured, though lower patient dose generally lowers scatter to the team.

At a glance

Type of study
Original research, Retrospective cohort study
Who was studied
Patients
Size
n = 150 patients
Summary based on
the abstract

What it found

  • After switching from 4 to 2 frames per second and removing the antiscatter grid, dose area product fell by 64%.

    Key figures: 630.28 ± 550.96 vs. 226.44 ± 277.44 µGym2, P < 0.001

  • Fluoroscopy duration was not prolonged under the new protocol.

    Key figures: 14.22 ± 4.47 vs. 13.62 ± 7.11 min, P = 0.066

  • Procedural duration did not differ.

    Key figures: 1:48 ± 0:28 vs. 1:53 ± 0:34, P = 0.525

  • Acute success was achieved in all procedures, with two complications before and one after the protocol change.

    Key figures: 100% acute success; 2 vs. 1 complications

  • The grid was re-introduced in four procedures because of poor visibility in morbidly obese patients or difficult transseptal puncture.

    Key figures: n = 4

Limits to keep in mind

Single-centre before-after comparison of 150 consecutive patients, not randomized. Only patient dose area product was reported, with no direct staff dosimetry.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.